Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal & Compliance
Shares
4,080
Price
$8.83
Total Value
$36.01K
Shares Held After
49,919
% of Holdings
7.6%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Sangiovanni Timothy J. — SVP, Finance & Corp Controller
Shares
1,750
Price
$8.82
Total Value
$15.44K
Shares Held After
20,924
% of Holdings
7.7%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
2,906
Price
$29.00
Total Value
$84.27K
Shares Held After
986,667
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
22,094
Price
$28.27
Total Value
$624.67K
Shares Held After
989,573
% of Holdings
2.2%
Aprea Therapeutics, Inc. (APRE)
Hamill John P. — SrVP/CFO/Prin Fin & Acct Ofcr
Shares
5,700
Price
$0.89
Total Value
$5.07K
Shares Held After
33,433
% of Holdings
17.0%
Aprea Therapeutics, Inc. (APRE)
Gilad Oren — Director
Shares
28,100
Price
$0.89
Total Value
$25.01K
Shares Held After
373,720
% of Holdings
7.5%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
6,612
Price
$18.11
Total Value
$119.74K
Shares Held After
365,273
% of Holdings
1.8%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
98
Price
$17.37
Total Value
$1.70K
Shares Held After
83,672
% of Holdings
0.1%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
4,797
Price
$16.58
Total Value
$79.55K
Shares Held After
83,770
% of Holdings
5.4%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
73
Price
$17.37
Total Value
$1.27K
Shares Held After
45,427
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
3,588
Price
$16.58
Total Value
$59.50K
Shares Held After
45,500
% of Holdings
7.3%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
88
Price
$17.37
Total Value
$1.53K
Shares Held After
57,010
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
4,333
Price
$16.58
Total Value
$71.85K
Shares Held After
57,098
% of Holdings
7.1%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
15,284
Price
$4.32
Total Value
$66.03K
Shares Held After
565,045
% of Holdings
2.6%
DBV Technologies S.A. (DBVT)
Mohideen Pharis — Chief Medical Officer
Shares
534
Price
$4.86
Total Value
$2.60K
Shares Held After
144,995
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
63
Price
$103.39
Total Value
$6.51K
Shares Held After
58,117
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,819
Price
$102.67
Total Value
$186.76K
Shares Held After
58,180
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,429
Price
$101.80
Total Value
$349.07K
Shares Held After
59,999
% of Holdings
5.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
189
Price
$100.95
Total Value
$19.08K
Shares Held After
63,428
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
8,667
Price
$29.74
Total Value
$257.78K
Shares Held After
986,667
% of Holdings
0.9%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
16,333
Price
$29.19
Total Value
$476.80K
Shares Held After
995,334
% of Holdings
1.6%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
2,800
Price
$45.01
Total Value
$126.02K
Shares Held After
10,503
% of Holdings
21.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,500
Price
$44.04
Total Value
$154.15K
Shares Held After
13,303
% of Holdings
20.8%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
1,200
Price
$43.18
Total Value
$51.82K
Shares Held After
16,803
% of Holdings
6.7%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
21,262
Price
$18.55
Total Value
$394.41K
Shares Held After
371,885
% of Holdings
5.4%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
664
Price
$19.05
Total Value
$12.65K
Shares Held After
393,147
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
5,860
Price
$18.61
Total Value
$109.05K
Shares Held After
393,811
% of Holdings
1.5%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
811
Price
$14.48
Total Value
$11.75K
Shares Held After
0
% of Holdings
100.0%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
2,800
Price
$14.09
Total Value
$39.44K
Shares Held After
811
% of Holdings
77.5%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
191
Price
$6.59
Total Value
$1.26K
Shares Held After
17,476
% of Holdings
1.1%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
46,000
Price
$2.17
Total Value
$99.81K
Shares Held After
989,925
% of Holdings
4.4%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
50
Price
$7.03
Total Value
$351.50
Shares Held After
22,622
% of Holdings
0.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
32,612
Price
$31.80
Total Value
$1.04M
Shares Held After
24,353
% of Holdings
57.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,695
Price
$8.45
Total Value
$14.32K
Shares Held After
249,301
% of Holdings
0.7%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,686
Price
$8.45
Total Value
$22.70K
Shares Held After
420,047
% of Holdings
0.6%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
1,354
Price
$8.45
Total Value
$11.44K
Shares Held After
276,610
% of Holdings
0.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
6,500
Price
$3.57
Total Value
$23.19K
Shares Held After
0
% of Holdings
100.0%
Anixa Biosciences, Inc. (ANIX)
Baskies Arnold M — Director
Shares
10,000
Price
$3.04
Total Value
$30.40K
Shares Held After
135,000
% of Holdings
7.4%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,671
Price
$3.00
Total Value
$8.02K
Shares Held After
173,999
% of Holdings
1.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
8,717
Price
$4.91
Total Value
$42.80K
Shares Held After
580,329
% of Holdings
1.5%
Celcuity Inc. (CELC)
Dalvey David — Director
Shares
20,000
Price
$120.03
Total Value
$2.40M
Shares Held After
90,000
% of Holdings
18.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
39,816
Price
$32.62
Total Value
$1.30M
Shares Held After
24,353
% of Holdings
62.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
100
Price
$57.05
Total Value
$5.71K
Shares Held After
449,944
% of Holdings
0.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
13,820
Price
$7.62
Total Value
$105.31K
Shares Held After
250,996
% of Holdings
5.2%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
18,895
Price
$7.62
Total Value
$143.98K
Shares Held After
422,733
% of Holdings
4.3%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
11,684
Price
$7.62
Total Value
$89.03K
Shares Held After
277,964
% of Holdings
4.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,139
Price
$5.08
Total Value
$21.03K
Shares Held After
589,046
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
51,865
Price
$30.10
Total Value
$1.56M
Shares Held After
419,173
% of Holdings
11.0%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
4,068
Price
$83.19
Total Value
$338.42K
Shares Held After
574,505
% of Holdings
0.7%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
18,203
Price
$83.14
Total Value
$1.51M
Shares Held After
60,320
% of Holdings
23.2%
Showing 2051–2100 of 3515 transactions (page 42 of 71)